Home » Authors » James Etheridge

Articles by James Etheridge

GenOway Signs 2 Agreements to Provide Mouse-Rat Lines

April 9, 2008

By James Etheridge

BioAlliance, Handok Team for Loramyc Distribution

April 2, 2008

By James Etheridge

Mapreg Gets Orphan Status for Spinal Cord Injury Drug

March 26, 2008

By James Etheridge

Cellectis in Suit with Precision for Patent Infringement

March 19, 2008

By James Etheridge

TxCell Completes €10.5M Round and Begins First Clinical Trial

March 12, 2008

By James Etheridge

No Abstract

Trophos Gets $1.4M Grant to Validate Drug in IRI

March 5, 2008

By James Etheridge

NicOx Begins Osteo Trials of Anti-Inflammatory Naproxcinod

March 5, 2008

By James Etheridge

NicOx Begins Osteo Trials of Anti-Inflammatory Naproxcinod

March 5, 2008

By James Etheridge

Trophos Gets $1.4M Grant to Validate Drug in IRI

March 5, 2008

By James Etheridge

Immtech Drops Pafuramidine Due to Liver Safety Concerns

Feb. 27, 2008

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 11, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 11, 2024.
Boryung invests $10M in Intuitive Machines for outer space R&D
BioWorld
Following its $60 million investment in Axiom Space Inc. last year, Boryung Co. Ltd. made a $10 million private placement in Intuitive Machines Inc. to grow its...
Phase II Huntington’s tie-up with Novartis could edge $3B for PTC
BioWorld
PTC Therapeutics Inc. said a “highly competitive process with several parties involved” led to the deal centered on the firm’s Huntington’s disease program with...
Elevar nabs Relay’s FGFR2 rare cancer drug in $500M deal
BioWorld
Elevar Therapeutics Inc. will license Relay Therapeutics Inc.’s “NDA-ready” bile duct cancer therapy, lirafugratinib (RLY-4008), through a potential $500 million...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.